NCT04672655View on ClinicalTrials.gov

Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

September 16, 2024

Study Completion Date

September 16, 2024

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

ONBOARD

Session 1: Overview; Wearing diabetes devices; Session 2: Managing CGM data; Session 3: CGM \& social situations; Session 4: Building trust with your CGM

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Molly Tanenbaum

OTHER

NCT04672655 - Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial | Biotech Hunter | Biotech Hunter